142 related articles for article (PubMed ID: 15817666)
1. Increased pituitary vascular endothelial growth factor-a in dopaminergic D2 receptor knockout female mice.
Cristina C; Díaz-Torga G; Baldi A; Góngora A; Rubinstein M; Low MJ; Becú-Villalobos D
Endocrinology; 2005 Jul; 146(7):2952-62. PubMed ID: 15817666
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory effects of antivascular endothelial growth factor strategies in experimental dopamine-resistant prolactinomas.
Luque GM; Perez-Millán MI; Ornstein AM; Cristina C; Becu-Villalobos D
J Pharmacol Exp Ther; 2011 Jun; 337(3):766-74. PubMed ID: 21406548
[TBL] [Abstract][Full Text] [Related]
3. Fibroblast growth factor-2 in hyperplastic pituitaries of D2R knockout female mice.
Cristina C; Díaz-Torga G; Góngora A; Guida MC; Perez-Millán MI; Baldi A; Becu-Villalobos D
Am J Physiol Endocrinol Metab; 2007 Nov; 293(5):E1341-51. PubMed ID: 17848635
[TBL] [Abstract][Full Text] [Related]
4. Dopaminergic D2 receptor knockout mouse: an animal model of prolactinoma.
Cristina C; García-Tornadú I; Díaz-Torga G; Rubinstein M; Low MJ; Becú-Villalobos D
Front Horm Res; 2006; 35():50-63. PubMed ID: 16809922
[TBL] [Abstract][Full Text] [Related]
5. Implication of pituitary vasoactive intestinal peptide in dopaminergic inhibition of estrogen-induced pituitary hyperplasia and vascular endothelial growth factor expression.
Gómez O; Balsa JA
Neuroendocrinology; 2004; 80(5):324-31. PubMed ID: 15677882
[TBL] [Abstract][Full Text] [Related]
6. Autocrine/paracrine action of pituitary vasoactive intestinal peptide on lactotroph hyperplasia induced by estrogen.
Gómez O; Balsa JA
Endocrinology; 2003 Oct; 144(10):4403-9. PubMed ID: 12960047
[TBL] [Abstract][Full Text] [Related]
7. Pituitary lactotroph adenomas develop after prolonged lactotroph hyperplasia in dopamine D2 receptor-deficient mice.
Asa SL; Kelly MA; Grandy DK; Low MJ
Endocrinology; 1999 Nov; 140(11):5348-55. PubMed ID: 10537166
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory effect of thalidomide on the growth, secretory function and angiogenesis of estrogen-induced prolactinoma in Fischer 344 rats.
Stepień H; Lawnicka H; Mucha S; Wagrowska-Danilewicz M; Stepień B; Siejka A; Komorowski J
Life Sci; 2006 Sep; 79(18):1741-8. PubMed ID: 16846617
[TBL] [Abstract][Full Text] [Related]
9. PTTG expression in different experimental and human prolactinomas in relation to dopaminergic control of lactotropes.
Cristina C; Díaz-Torga GS; Goya RG; Kakar SS; Perez-Millán MI; Passos VQ; Giannella-Neto D; Bronstein MD; Becu-Villalobos D
Mol Cancer; 2007 Jan; 6():4. PubMed ID: 17222350
[TBL] [Abstract][Full Text] [Related]
10. Disruption of the D2 dopamine receptor alters GH and IGF-I secretion and causes dwarfism in male mice.
Díaz-Torga G; Feierstein C; Libertun C; Gelman D; Kelly MA; Low MJ; Rubinstein M; Becú-Villalobos D
Endocrinology; 2002 Apr; 143(4):1270-9. PubMed ID: 11897683
[TBL] [Abstract][Full Text] [Related]
11. Platelet-activating factor (PAF) induces corneal neovascularization and upregulates VEGF expression in endothelial cells.
Ma X; Ottino P; Bazan HE; Bazan NG
Invest Ophthalmol Vis Sci; 2004 Sep; 45(9):2915-21. PubMed ID: 15326102
[TBL] [Abstract][Full Text] [Related]
12. Ovarian dependence for pituitary tumorigenesis in D2 dopamine receptor-deficient mice.
Hentges ST; Low MJ
Endocrinology; 2002 Dec; 143(12):4536-43. PubMed ID: 12446580
[TBL] [Abstract][Full Text] [Related]
13. The effects of dopamine and D2 receptor antagonists on pituitary hormone secretion are intact in mice lacking dopamine D2L receptor.
Xu R; Parlow AF; Wang Y
Brain Res; 2002 Jun; 939(1-2):95-9. PubMed ID: 12020855
[TBL] [Abstract][Full Text] [Related]
14. Fetal Alcohol Exposure Reduces Dopamine Receptor D2 and Increases Pituitary Weight and Prolactin Production via Epigenetic Mechanisms.
Gangisetty O; Wynne O; Jabbar S; Nasello C; Sarkar DK
PLoS One; 2015; 10(10):e0140699. PubMed ID: 26509893
[TBL] [Abstract][Full Text] [Related]
15. [The relationship between expression of the vascular endothelial growth factor and acute leukemia subtype].
Ye XJ; Lin MF
Zhonghua Xue Ye Xue Za Zhi; 2005 Jun; 26(6):363-6. PubMed ID: 16185486
[TBL] [Abstract][Full Text] [Related]
16. Glucagon like peptide-2 induces intestinal restitution through VEGF release from subepithelial myofibroblasts.
Bulut K; Pennartz C; Felderbauer P; Meier JJ; Banasch M; Bulut D; Schmitz F; Schmidt WE; Hoffmann P
Eur J Pharmacol; 2008 Jan; 578(2-3):279-85. PubMed ID: 17920582
[TBL] [Abstract][Full Text] [Related]
17. Disruption of the dopamine d2 receptor impairs insulin secretion and causes glucose intolerance.
García-Tornadú I; Ornstein AM; Chamson-Reig A; Wheeler MB; Hill DJ; Arany E; Rubinstein M; Becu-Villalobos D
Endocrinology; 2010 Apr; 151(4):1441-50. PubMed ID: 20147524
[TBL] [Abstract][Full Text] [Related]
18. Vascular endothelial growth factor, its receptor KDR/Flk-1, and pituitary tumor transforming gene in pituitary tumors.
McCabe CJ; Boelaert K; Tannahill LA; Heaney AP; Stratford AL; Khaira JS; Hussain S; Sheppard MC; Franklyn JA; Gittoes NJ
J Clin Endocrinol Metab; 2002 Sep; 87(9):4238-44. PubMed ID: 12213878
[TBL] [Abstract][Full Text] [Related]
19. Selective disruption of dopamine D2 receptors in pituitary lactotropes increases body weight and adiposity in female mice.
Perez Millan MI; Luque GM; Ramirez MC; Noain D; Ornstein AM; Rubinstein M; Becu-Villalobos D
Endocrinology; 2014 Mar; 155(3):829-39. PubMed ID: 24424036
[TBL] [Abstract][Full Text] [Related]
20. Partial agonist properties of the antipsychotics SSR181507, aripiprazole and bifeprunox at dopamine D2 receptors: G protein activation and prolactin release.
Cosi C; Carilla-Durand E; Assié MB; Ormiere AM; Maraval M; Leduc N; Newman-Tancredi A
Eur J Pharmacol; 2006 Mar; 535(1-3):135-44. PubMed ID: 16554049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
